000 | 03096 a2200877 4500 | ||
---|---|---|---|
005 | 20250515065716.0 | ||
264 | 0 | _c20070716 | |
008 | 200707s 0 0 eng d | ||
022 | _a1592-8721 | ||
024 | 7 |
_a10.3324/haematol.10965 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpinelli, Orietta | |
245 | 0 | 0 |
_aClearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bHaematologica _cMay 2007 |
||
300 |
_a612-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBasic Helix-Loop-Helix Transcription Factors _xgenetics |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xblood |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aGene Rearrangement, B-Lymphocyte |
650 | 0 | 4 | _aGene Rearrangement, T-Lymphocyte |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLeukemia-Lymphoma, Adult T-Cell _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMulticenter Studies as Topic |
650 | 0 | 4 |
_aMyeloid-Lymphoid Leukemia Protein _xblood |
650 | 0 | 4 | _aNeoplasm, Residual |
650 | 0 | 4 |
_aOncogene Proteins, Fusion _xblood |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xblood |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aT-Cell Acute Lymphocytic Leukemia Protein 1 |
650 | 0 | 4 | _aTranslocation, Genetic |
650 | 0 | 4 | _aTransplantation Conditioning |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPeruta, Barbara | |
700 | 1 | _aTosi, Manuela | |
700 | 1 | _aGuerini, Vittoria | |
700 | 1 | _aSalvi, Anna | |
700 | 1 | _aZanotti, Maria Cristina | |
700 | 1 | _aOldani, Elena | |
700 | 1 | _aGrassi, Anna | |
700 | 1 | _aIntermesoli, Tamara | |
700 | 1 | _aMicò, Caterina | |
700 | 1 | _aRossi, Giuseppe | |
700 | 1 | _aFabris, Pietro | |
700 | 1 | _aLambertenghi-Deliliers, Giorgio | |
700 | 1 | _aAngelucci, Emanuele | |
700 | 1 | _aBarbui, Tiziano | |
700 | 1 | _aBassan, Renato | |
700 | 1 | _aRambaldi, Alessandro | |
773 | 0 |
_tHaematologica _gvol. 92 _gno. 5 _gp. 612-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.10965 _zAvailable from publisher's website |
999 |
_c17034692 _d17034692 |